May 7th 2024
New data from a World Health Organization (WHO) repository illustrates the treatment challenges during the acute phase of the pandemic.
Antibiotic Resistance Rises After PCV13 Vaccine Introduced to Fight Pneumococcal Disease
March 6th 2020Investigators in Rochester, NY, detailed the emergence of 3 antibiotic-resistant strains of Streptococcus pneumoniae since the introduction of the 13-valent pneumococcal conjugate vaccine in 2010.
Read More
New Monoclonal Antibody Treatment Takes Aim at Bacterial Biofilms
March 3rd 2020Investigators have shown that a new monoclonal antibody treatment is able to break apart communities of harmful bacteria, which could aid existing antibiotic treatments in more efficiently clearing out infections.
Read More
Antibiotic Exposure Following HCT Increases Risk for Respiratory Viral Disease Progression
February 24th 2020Progression to lower respiratory tract disease was associated with higher total antibiotic-days, use of antibiotics with broad anaerobic activity, and use of cephalosporins with limited anaerobic activity.
Read More
Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Read More
Observing Microbiome Changes After Single-Dose Antibiotics for Traveler's Diarrhea
February 18th 2020Mark Riddle, MD, DrPH, speaks to Contagion at ACG 2019 about the results of a study looking into microbiome changes associated with single-dose antibiotics for the treatment of traveler's diarrhea.
Watch